ES2364314T8 - Detección y predicción de preeclampsia. - Google Patents

Detección y predicción de preeclampsia. Download PDF

Info

Publication number
ES2364314T8
ES2364314T8 ES07700392T ES07700392T ES2364314T8 ES 2364314 T8 ES2364314 T8 ES 2364314T8 ES 07700392 T ES07700392 T ES 07700392T ES 07700392 T ES07700392 T ES 07700392T ES 2364314 T8 ES2364314 T8 ES 2364314T8
Authority
ES
Spain
Prior art keywords
preeclampsy
preaching
detection
technology described
predicting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07700392T
Other languages
English (en)
Other versions
ES2364314T3 (es
Inventor
Lucilla Poston
Andrew Shennan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Application granted granted Critical
Publication of ES2364314T3 publication Critical patent/ES2364314T3/es
Publication of ES2364314T8 publication Critical patent/ES2364314T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
ES07700392T 2006-01-17 2007-01-17 Detección y predicción de preeclampsia. Active ES2364314T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
GB0600916 2006-01-17

Publications (2)

Publication Number Publication Date
ES2364314T3 ES2364314T3 (es) 2011-08-31
ES2364314T8 true ES2364314T8 (es) 2011-09-22

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07700392T Active ES2364314T3 (es) 2006-01-17 2007-01-17 Detección y predicción de preeclampsia.

Country Status (10)

Country Link
US (1) US7638287B2 (es)
EP (1) EP1974220B1 (es)
JP (1) JP2009524014A (es)
AT (1) ATE504002T1 (es)
AU (1) AU2007206756B2 (es)
CA (1) CA2602681C (es)
DE (1) DE602007013524D1 (es)
ES (1) ES2364314T3 (es)
GB (1) GB0600916D0 (es)
WO (1) WO2007083099A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ578077A (en) 2007-02-12 2012-04-27 Stefan Hansson Diagnosis of preeclampsia using free foetal haemoglobin
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
EP2657697B1 (en) 2008-01-25 2016-06-08 Wallac Oy Methods for determining the risk of chromosomal abnormality in a fetus
EP2368119B1 (en) * 2008-11-20 2014-04-23 PerkinElmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
PT2550535E (pt) * 2010-03-24 2015-09-07 Preelumina Diagnostics Ab Hbf e a1m como marcadores de fase inicial para pré- eclâmpsia
AU2012351504C1 (en) * 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
ES2718905T3 (es) * 2012-04-24 2019-07-05 Siemens Healthcare Diagnostics Inc Métodos de examen de preeclampsia
CA2900366A1 (en) 2013-02-08 2014-08-14 University Of Iowa Research Foundation Diagnostic tools to predict onset of preeclampsia
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
US10656163B2 (en) 2014-09-02 2020-05-19 Wallac Oy Method for determining risk of pre-eclampsia
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
WO2019099998A1 (en) * 2017-11-17 2019-05-23 University Of Washington Connected system for information-enhanced test results
WO2021113710A1 (en) 2019-12-04 2021-06-10 Progenity, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5331298A (en) 1996-12-23 1998-07-17 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
CA2539430C (en) * 2003-09-23 2015-03-17 The General Hospital Corporation Screening for gestational disorders with sex hormone binding globulin as biomarker
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
AU2007206756B2 (en) 2011-06-16
US7638287B2 (en) 2009-12-29
CA2602681A1 (en) 2007-07-26
ATE504002T1 (de) 2011-04-15
ES2364314T3 (es) 2011-08-31
DE602007013524D1 (de) 2011-05-12
GB0600916D0 (en) 2006-02-22
US20070178530A1 (en) 2007-08-02
WO2007083099A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
EP1974220B1 (en) 2011-03-30
HK1119244A1 (en) 2009-02-27
JP2009524014A (ja) 2009-06-25
EP1974220A1 (en) 2008-10-01
AU2007206756A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
BR112012030788B8 (pt) Anticorpo monoclonal, linhagem celular de hibridoma, e métodos para identificar a presença e para determinação quantitativa de uma enzima aad-12
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
EP4697020A3 (en) Compositions and methods for analyte detection
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
BR112013006240A2 (pt) processo para detecção, diferenciação e quantificação de populações de células-t através da tecnologia quantitativa pcr (rt-qpcr) de transcrição reversa, em tempo real
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
MX2007011510A (es) Metodo y aparato para proveer informacion de tiempo de viaje y congestion a usuarios.
WO2014065889A3 (en) Multiplexed method for diagnosing classical hodgkin lymphoma
IN2014CN01787A (es)
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
BRPI1013896A2 (pt) Célula de levedura, e, métodos para produzir um composto isoprenóide e para detectar em uma amostra biológica a presença ou ausência de uma célula microbiana geneticamente.
WO2012170206A3 (en) Color-producing diagnostic systems, reagents and methods
WO2010075360A3 (en) Methods for detection of sepsis
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
WO2008150010A1 (ja) γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009129173A3 (en) Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
WO2012025637A9 (en) An agglutination assay method and device
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins